Literature DB >> 2896890

Declining levels of HIV P24 antigen in serum during treatment with foscarnet.

S Bergdahl, A Sönnerborg, A Larsson, O Strannegard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2896890     DOI： 10.1016/s0140-6736(88)91867-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet.

Authors:  R Koshida; L Vrang; G Gilljam; J Harmenberg; B Oberg; B Wahren
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

Review 2.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

Review 3.  AIDS and the lung. 2--Antiretroviral treatment in human immunodeficiency virus disease.

Authors:  A J Pinching
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

4.  Evaluation of two enzyme immunoassays for detection of human immunodeficiency virus antigen in African and European sera.

Authors:  G Vercauteren; P Piot; M Vandenbruaene; G van der Groen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

5.  Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome.

Authors:  A Karpas; F Hill; M Youle; V Cullen; J Gray; N Byron; F Hayhoe; M Tenant-Flowers; L Howard; D Gilgen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 6.  Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).

Authors:  E Sandström; B Oberg
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

Review 7.  Antiviral therapy in human immunodeficiency virus infection.

Authors:  E Sandström
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

8.  Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection.

Authors:  J Sjövall; S Bergdahl; G Movin; S Ogenstad; M Saarimäki
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.